Atherosclerotic occlusion afflicts millions of patients annually. One method of treatment is the use of a vascular graft to bypass the affected region. Salubria™ biomaterial may have application as a durable, thromboresistant vascular graft.

	Disclaimer: The matters discussed herein may include forward-looking statements that involve risks and uncertainties. No assurance can be given that the Company will successfully complete these objectives.